Maximizing Automation in the IV Compounding Process
By David F. Webster, BS Pharm, MSBA
The risks of error or contamination in the sterile IV compounding process are well documented, and pharmacy leaders have been actively seeking ways to reduce these risks in recent years. The University of Rochester Medical Center (URMC) has prioritized technology implementations to increase safety in a wide range of sterile production, including neonatal doses and hazardous medications. Our goal was to adopt a complete automation solution to address all types of preparations across all patient populations. To that end, we chose a safety technology solution that includes a non-hazardous IV compounding robot, hazardous IV compounding robots, IV workflow automation, and human-assist device robotics. To read about how URMC maximized these technologies, CLICK HERE.
Did You Know . . .
Safe Parenteral Nutrition Prescribing and Order Review
By Phil Ayers, PharmD, BCNSP, FASHP; Jenny Anderson, MS, RD, LD, CNSC; Carman Dixon, PharmD; and Andrew Mays, PharmD, CNSC
Parenteral nutrition (PN), a complex prescription therapy, is designated a high-alert medication by ISMP.1 Despite this classification, a recent PN use survey with gap analysis reported that only 56% of organizations have precautions in place to prevent errors and patient harm associated with PN.2 The ASPEN Parenteral Nutrition Safety Consensus Recommendations address safety concerns throughout the PN process, including prescribing, order review and verification, compounding, and administration of PN.3 Compliance with the ASPEN recommendations is critical to prevent PN errors and avert the potential for patient harm throughout the PN process; thus, organizations must ensure they fully understand and implement the recommendations. To read about how to address errors that may occur during PN prescribing, order review, and verification, CLICK HERE. References: 1) ISMP's List of High-Alert Medications in Acute Care Settings (2014). www.ismp.org/tools/highalertmedications.pdf. 2) Boullata JI, et al. JPEN J Parenter Enteral Nutr. 2013;37(2):212-222. 3) Ayers P, et al. JPEN J Parenter Enteral Nutr. 2014;38(3):296-333.
Your Subscription
You are receiving this message as a subscriber to Pharmacy Purchasing & Products. If you would like to unsubscribe from our newsletters, please visit www.pppmag.com/unsubscribe. If you are not already a subscriber to Pharmacy Purchasing & Products and would like to subscribe please go to: www.pppmag.com/subscribe. Please remember to add us to your address book to ensure that you continue to receive our emails in your inbox. Sponsorship/Advertising Opportunities Please contact your account manager at sales@ridgewoodmedia.com or call 201-670-0077, ext. 200. In the Loop © 2017 Ridgewood Medical Media, LLC. You have permission to forward In the Loop, in its entirety only, provided this copyright notice remains part of your transmission. To subscribe to In the Loop, please send an email to: listmanager@ridgewoodmedia.com and type "Subscribe, (Your email address, and full name)" in the body. All other rights reserved. None of this material may be reprinted without the express written permission of Ridgewood Medical Media, LLC. |